Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of company at it''s meeting held on 22.11.2024 has approved the quarterly ....
Awaiting price reaction for this filing.
Nutraplus India Ltd reported a net loss of Rs 2.71 lakh for Q3 FY2023-24 (Dec 2023), compared to a loss of Rs 1.07 lakh in the same quarter last year. The company posted near-zero revenue from operations (other income of just Rs 0.10 lakh), continuing its loss-making trend with a 9-month loss of Rs 4.09 lakh. The auditor issued a qualified limited review report due to the company's failure to submit results within prescribed timelines and incomplete financial data. Critically, the company has lost all its property, plant and equipment under the SARFAESI Act, 2002, after being declared a Non-Performing Asset in FY 2019-20. COVID-19 further delayed the bank's auction process. Results for Q3 December 2023 are being filed nearly a year late (November 2024).
This filing reveals a company that has effectively ceased operations, lost all its assets, and is non-compliant with listing obligations. The qualified auditor opinion and emphasis of matter regarding asset auction under SARFAESI raise severe going concern doubts. Shareholders face extreme risk as the company may be delisted or become a shell entity.